8-K
Current Report
NEKTAR THERAPEUTICS Filed Acc 0001193125-26-214976
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d159808d8k.htm…